Showing results (231-240 of 281) with videos related to
Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Macrophage inflammatory protein 1alpha attenuates the toxic effects of temozolomide in human bone marrow granulocyte-macrophage colony-forming cellsM Clemons, A Watson, A Howell, et al.Lancet (London, England)|July 11, 1992
Growth of human umbilical-cord blood in longterm haemopoietic culturesJ M Hows, B A Bradley, J C Marsh, et al.Biochemical Pharmacology|June 1, 1989
The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivoM J Lind, A T McGown, J A Hadfield, et al.Blood|March 1, 1997
O6-benzylguanine potentiates the in vivo toxicity and clastogenicity of temozolomide and BCNU in mouse bone marrowN Chinnasamy, J A Rafferty, I Hickson, et al.British Journal of Haematology|February 1, 1977
Bone marrow culture studies in refractory cytopenia and 'smouldering leukaemia'G R Milner, N G Testa, C G Geary, et al.Blood|January 1, 1997
Identification of a serpin specifically expressed in multipotent and bipotent hematopoietic progenitor cells and in activated T cellsI N Hampson, L Hampson, M Pinkoski, et al.British Journal of Cancer|July 1, 1992
Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections--a phase I dose toxicity trialM H Gilleece, J H Scarffe, A Ghosh, et al.Leukemia|December 22, 1999
Characterisation of the differential response of normal and CML haemopoietic progenitor cells to macrophage inflammatory protein-1alphaJ Dürig, N G Testa, B I Lord, et al.Lancet (London, England)|February 5, 1998
Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplantsR F Wynn, M A Cross, C Hatton, et al.Cytokine|January 1, 1992
Biological and structural properties of MIP-1 alpha expressed in yeastJ M Clements, S Craig, A J Gearing, et al.Pageof 29